Medicofarma Biotech SA
WSE:MDB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medicofarma Biotech SA
Operating Income
Medicofarma Biotech SA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Operating Income
-zł2.1m
|
CAGR 3-Years
-93%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Operating Income
-zł10.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Operating Income
-zł97.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
S
|
Selvita SA
WSE:SLV
|
Operating Income
zł10.7m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Medicofarma Biotech SA
Glance View
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
See Also
What is Medicofarma Biotech SA's Operating Income?
Operating Income
-2.1m
PLN
Based on the financial report for Dec 31, 2024, Medicofarma Biotech SA's Operating Income amounts to -2.1m PLN.
What is Medicofarma Biotech SA's Operating Income growth rate?
Operating Income CAGR 5Y
-41%
Over the last year, the Operating Income growth was 40%. The average annual Operating Income growth rates for Medicofarma Biotech SA have been -93% over the past three years , -41% over the past five years .
